NSC-698037
Showing 1 - 25 of 48
Urothelial Carcinoma, Metastatic Cancer Trial in Houston (Pemetrexed, Zimberelimab, Etrumadenant)
Not yet recruiting
- Urothelial Carcinoma
- Metastatic Cancer
- Pemetrexed
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Nov 28, 2022
Lung Cancer Trial in Houston (AMG 510, Cisplatin, Carboplatin)
Recruiting
- Lung Cancer
- AMG 510
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 10, 2022
Advanced Cancers Trial in Houston (Crizotinib (Xalkori), Pazopanib, Pemetrexed)
Terminated
- Advanced Cancers
- Crizotinib (Xalkori)
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 3, 2021
Lung Cancer Trial in Houston (Carboplatin, Pemetrexed, Bevacizumab)
Completed
- Lung Cancer
- Carboplatin
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 13, 2019
DLBCL (DLBCL), Primary Mediastinal Large B-cell Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)
Active, not recruiting
- Diffuse Large B-Cell Lymphoma (DLBCL)
- +4 more
- EPOCH
- Rituximab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte
Withdrawn
- Recurrent Anaplastic Astrocytoma
- +7 more
- Neural Stem Cells-expressing CRAd-S-pk7
- Resection
- (no location specified)
Nov 22, 2022
Dementia Trial in Málaga (Nordic Sensi Chair)
Completed
- Dementia
- Nordic Sensi Chair
-
Málaga, SpainInstituto Andaluz de Neurociencia
Jan 30, 2023
Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)
Recruiting
- Glioblastoma Multiforme
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 30, 2023
On Craniosynostosis, Skull Malformations With Premature Fusion
Recruiting
- Craniosynostosis
- Craniosynostosis Network Environmental Survey
- +6 more
-
Davis, California
- +19 more
Jul 5, 2022
From Skin Fibroblasts to Neural Stem Cells to Investigate in
Active, not recruiting
- Diabetes Mellitus, Type 2
- +5 more
- Skin biopsy
-
Roma, ItalyMingrone Geltrude
Mar 8, 2023
NSCLC, Bone Metastases Trial in France (Denosumab-nivolumab combination)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Bone Metastases
- Denosumab-nivolumab combination
-
Aix-en-Provence, France
- +26 more
Jul 19, 2022
Executive Function of School-aged Children With ASD Trial in Taipei City (VR game intervention)
Recruiting
- Executive Function of School-aged Children With ASD
- VR game intervention
-
Taipei City, State, TaiwanNational Taiwan Normal University
Nov 12, 2023
Complex Post-Traumatic Stress Disorder Trial in Leatherhead (Enhanced Skills Training in Affective and Interpersonal Regulation,
Recruiting
- Complex Post-Traumatic Stress Disorder
- Enhanced Skills Training in Affective and Interpersonal Regulation
- Treatment as usual
-
Leatherhead, Surrey, United KingdomCombat Stress
Apr 22, 2022
Cervical Cancer Trial in United States (cisplatin, pemetrexed disodium)
Completed
- Cervical Cancer
- cisplatin
- pemetrexed disodium
-
Los Angeles, California
- +11 more
Dec 12, 2017
Parkinson Disease Trial in Rouen (Directional and single ring STN-DBS on gait)
Unknown status
- Parkinson Disease
- Directional and single ring STN-DBS on gait
-
Rouen, FranceCHU de ROUEN
Jun 2, 2020
Lung Cancer Trial in Houston (Alimta)
Completed
- Lung Cancer
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 20, 2016
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Houston (saracatinib, laboratory
Terminated
- Adenocarcinoma of the Colon
- +5 more
- saracatinib
- laboratory biomarker analysis
-
Houston, TexasM D Anderson Cancer Center
Jul 29, 2019
Child Behavior, Autism Spectrum Disorder, Psychiatric Hospitalization Trial (Activity)
Completed
- Child Behavior
- +3 more
- Activity
- (no location specified)
May 16, 2019
Pancreas Cancer Trial in Washington (pemetrexed)
Terminated
- Pancreas Cancer
-
Washington, District of ColumbiaGeorgetown University Hospital/Lombardi Cancer Center
Dec 7, 2015
Mesothelioma Trial in Houston (Cisplatin, Imatinib Mesylate, Pemetrexed)
Completed
- Mesothelioma
- Cisplatin
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 16, 2015
Parkinson Disease Trial in Suzhou (human neural stem cell)
Unknown status
- Parkinson Disease
- human neural stem cell
-
Suzhou, Jiangsu, ChinaDepartment of Neurology, Second Affiliated Hospital of Soochow U
Sep 13, 2017
Neurofibromatosis, Neurofibromas Trial in Indianapolis (Gleevec)
Completed
- Neurofibromatosis
- Neurofibromas
-
Indianapolis, IndianaRiley Hospital for Children
Jun 2, 2017
NSCLC Trial in Nanning (Icotinib, Pemetrexed, Carboplatin)
Unknown status
- Non-small Cell Lung Cancer
- Icotinib
- +3 more
-
Nanning, Guangxi, ChinaThe people's Hospital of the Guangxi Zhuang Autonomous Region
Mar 30, 2015
Non-Small-Cell Lung Carcinoma, Prostate Cancer, Bladder Cancer Trial in Ann Arbor (vorinostat (suberoylanilide hydroxamic acid),
Terminated
- Non-Small-Cell Lung Carcinoma
- +3 more
- vorinostat (suberoylanilide hydroxamic acid)
- docetaxel
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Dec 1, 2016